Position in MRNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$125,688,301
+$25,252,688 QoQ
Shares Held
1,794,778
-9.2% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#28
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. MRNA ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
This page
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,688,301 | 1,794,778 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $100,435,613 | 1,977,079 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $64,245,055 | 2,178,537 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $71,781,594 | 2,779,001 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $79,163,185 | 2,869,271 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,513,892 | 617,774 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $16,881 | 406 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $150,367 | 2,250 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $231,918 | 1,953 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $197,029 | 1,849 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $184,380 | 1,854 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $514,384 | 4,980 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $620,865 | 5,110 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,130,637 | 59,452 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $22,886,282 | 127,415 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $20,127,687 | 170,213 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,366,581 | 58,569 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $21,118,385 | 122,596 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $825,434 | 3,250 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $284,682,480 | 739,704 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $362,617,375 | 1,543,184 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $208,099,715 | 1,589,154 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $193,570,477 | 1,852,881 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $124,462,904 | 1,759,193 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $228,189,753 | 3,553,804 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $140,273,429 | 4,683,587 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||